Higher frequency of methicillin resistant bacteria in children with familial mediterranean fever

Abstract

Insights

Children with Familial Mediterranean Fever have higher rates of resistant bacteria in their nasal passages. This finding highlights potential risks for comorbidities associated with antibiotic resistance in this population.

Area of Science:

  • Microbiology
  • Pediatrics
  • Genetics

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
  • Children with FMF may be at increased risk for infections due to their condition or treatment.
  • Nasal carriage of resistant microorganisms is a growing public health concern.

Purpose of the Study:

  • To investigate the prevalence of resistant microorganisms in the nasal mucosa of children diagnosed with Familial Mediterranean Fever.
  • To compare the rates of resistant bacteria colonization between FMF patients and healthy controls.

Main Methods:

  • A case-control study was conducted with 73 children with FMF and 78 healthy controls.
  • Nasal swab samples were collected from all participants, excluding those with recent antibiotic or steroid use.
  • Standard microbiological methods were employed for strain identification and analysis of resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).

Main Results:

  • Resistant bacteria were isolated from 63% of FMF cases compared to controls (p=0.003), with an odds ratio of 2.7.
  • Methicillin-resistant coagulase-negative staphylococcus and methicillin-resistant Staphylococcus aureus were identified in both groups.
  • In healthy controls, a history of hospitalization significantly increased the risk of carrying resistant bacteria (OR: 7.7).

Conclusions:

  • Children with Familial Mediterranean Fever exhibit higher rates of nasal carriage of resistant bacteria.
  • The increased prevalence of resistant microorganisms suggests a heightened risk of comorbidities linked to antibiotic resistance in FMF patients.
  • Further research is warranted to understand the implications of these findings for FMF management and public health.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
143
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
89
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
129
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K